IDXG — Interpace Biosciences Share News
0.000.00%
Last trade - 00:00- $45.71m
- $43.06m
- $38.73m
Interpace Diagnostics: Jumps after health insurer covers co's cancer tests
Brief: Interpace Diagnostics Announces Coverage Of Molecular Thyroid Testing By Independence Blue Cross
Brief: Interpace Diagnostics Sees 2019 Revenue Up 25%
Brief: Interpace Diagnostics Announces Publication Of Important New Data On Thyroid Test Performance
Brief: Interpace Diagnostics Labs Receive College of American Pathology Accreditation
Brief: Interpace Diagnostics Says New York State Approves Commercialization Of Thyramir Now In Three Specimens
Brief: Interpace Diagnostics Announces New Coverage Of Thyroid Testing By Medica
Brief: Interpace Diagnostics Reports Q4 Loss/Share $0.14
Brief: Interpace Diagnostics Announces Preliminary 2018 Revenues
U.S. STOCKS ON THE MOVE-Intel, AbbVie, Ford, PG&E, Amazon, Starbucks
Interpace Diagnostics: Falls on $7 mln stock deal
Brief: Interpace Diagnostics Announces Pricing Of $7 Million Public Offering Of Common Stock
Brief: Interpace Diagnostics Announces Further Expansion Of Thyroid Business
Brief: Interpace Diagnostics Enters Agreement With University Of Maryland Medical System
U.S. STOCKS ON THE MOVE-FedEx, Jabil, Netflix, Micron, Analog Devices
Brief: Interpace Diagnostics Announces Notice Of Allowance From U.S. Patent And Trademark Office Covering Barregen
Brief: Interpace Diagnostics Group Q3 Loss Per Share $0.11
Brief: Interpace Diagnostics Announces New Coverage By Blue Cross Blue Shield For Thyroid Testing
Brief: Interpace Diagnostics Sees FY18 Revenue More Than $20 Mln